![Muthusamy Shanmugam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Muthusamy Shanmugam
Hoofd Techniek/Wetenschap/O&O bij ANI PHARMACEUTICALS, INC.
Vermogen: 49 M $ op 31-05-2024
Actieve functies van Muthusamy Shanmugam
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ANI PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 19-11-2021 | - |
Hoofd Techniek/Wetenschap/O&O | 19-11-2021 | - | |
Nuray Chemicals Pvt Ltd.
![]() Nuray Chemicals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Nuray Chemicals Pvt Ltd. provides pharmaceutical products. It offers nisoldipine, rasagiline mesylate, pioglitazone hydrochloride, rosiglitazone maleate, levofloxacin, paliperidone, atorvastatin calcium, ranolazine, sildenafil, pramipexole, and other related products. The company was founded on June 14, 2012 and is headquartered in Thiruvallur, India. | Directeur/Bestuurslid | 20-07-2016 | - |
Novitium Pharma LLC
![]() Novitium Pharma LLC Pharmaceuticals: OtherHealth Technology Part of ANI Pharmaceuticals, Inc., Novitium Pharma LLC is a pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The private company was founded in 2016 by Muthusamy Shanmugam, Chad Gassert, and Vijay Thorappadi and is based in East Windsor, NJ, with operations also in Chennai. Novitium has a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities. Novitium Pharma was acquired by ANI Pharmaceuticals, Inc. on November 22, 2021 for $243.40 million. | Directeur/Bestuurslid | 01-11-2021 | - |
Operationeel Directeur | 01-11-2021 | - | |
Hoofd Techniek/Wetenschap/O&O | 01-11-2021 | - | |
Oprichter | 01-01-2016 | - | |
President | 01-01-2016 | 01-11-2021 | |
Saimirra Innopharm Pvt Ltd.
![]() Saimirra Innopharm Pvt Ltd. Pharmaceuticals: MajorHealth Technology Saimirra Innopharm Pvt Ltd is an Indian pharmaceutical company that produces and exports pharmaceutical products. The private company is based in Chennai, India. The company was founded in 2000 by Jaganathan Jayaseelan. | Directeur/Bestuurslid | 22-10-2012 | - |
Loopbaan van Muthusamy Shanmugam
Opleiding van Muthusamy Shanmugam
The Tamil Nadu Dr. M.G.R. Medical University | Graduate Degree |
JSS College of Pharmacy | Graduate Degree |
Statistieken
Internationaal
India | 5 |
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Graduate Degree | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ANI PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Nuray Chemicals Pvt Ltd.
![]() Nuray Chemicals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Nuray Chemicals Pvt Ltd. provides pharmaceutical products. It offers nisoldipine, rasagiline mesylate, pioglitazone hydrochloride, rosiglitazone maleate, levofloxacin, paliperidone, atorvastatin calcium, ranolazine, sildenafil, pramipexole, and other related products. The company was founded on June 14, 2012 and is headquartered in Thiruvallur, India. | Health Technology |
Novitium Pharma LLC
![]() Novitium Pharma LLC Pharmaceuticals: OtherHealth Technology Part of ANI Pharmaceuticals, Inc., Novitium Pharma LLC is a pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The private company was founded in 2016 by Muthusamy Shanmugam, Chad Gassert, and Vijay Thorappadi and is based in East Windsor, NJ, with operations also in Chennai. Novitium has a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities. Novitium Pharma was acquired by ANI Pharmaceuticals, Inc. on November 22, 2021 for $243.40 million. | Health Technology |
Saimirra Innopharm Pvt Ltd.
![]() Saimirra Innopharm Pvt Ltd. Pharmaceuticals: MajorHealth Technology Saimirra Innopharm Pvt Ltd is an Indian pharmaceutical company that produces and exports pharmaceutical products. The private company is based in Chennai, India. The company was founded in 2000 by Jaganathan Jayaseelan. | Health Technology |
- Beurs
- Insiders
- Muthusamy Shanmugam
- Ervaring